SALL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.233000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.616800E-01
Normal-vs-Stage2
3.004800E-01
Normal-vs-Stage3
3.557400E-01
Normal-vs-Stage4
5.489200E-01
Stage1-vs-Stage2
2.566800E-01
Stage1-vs-Stage3
2.505000E-01
Stage1-vs-Stage4
2.865800E-01
Stage2-vs-Stage3
8.482800E-01
Stage2-vs-Stage4
7.446200E-01
Stage3-vs-Stage4
6.882000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.640400E-01
Normal-vs-AfricanAmerican
3.790200E-01
Normal-vs-Asian
3.383800E-01
Caucasian-vs-AfricanAmerican
6.379600E-01
Caucasian-vs-Asian
2.193600E-01
AfricanAmerican-vs-Asian
9.327600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.631000E-01
Normal-vs-Female
8.922800E-01
Male-vs-Female
6.387600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.671800E-01
Normal-vs-Age(41-60Yrs)
9.444400E-01
Normal-vs-Age(61-80Yrs)
6.761800E-01
Normal-vs-Age(81-100Yrs)
8.980300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.592400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.302400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.019800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.193400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.525920E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.338830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.780100E-02
Normal-vs-Daily Drinker
7.612600E-01
Normal-vs-Weekly Drinker
3.233000E-01
Normal-vs-Occasional Drinker
8.027800E-01
Normal-vs-Social Drinker
8.268800E-01
Non Drinker-vs-Daily Drinker
2.290000E-01
Non Drinker-vs-Weekly Drinker
1.834210E-01
Non Drinker-vs-Occasional Drinker
1.220990E-01
Non Drinker-vs-Social Drinker
9.046300E-02
Daily Drinker-vs-Weekly Drinker
6.545000E-01
Daily Drinker-vs-Occasional Drinker
8.487000E-01
Daily Drinker-vs-Social Drinker
3.540400E-01
Weekly Drinker-vs-Occasional Drinker
4.714200E-01
Weekly Drinker-vs-Social Drinker
2.127800E-01
Occasional Drinker-vs-Social Drinker
4.299800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.512600E-01
Normal-vs-Grade 2
4.948600E-01
Normal-vs-Grade 3
3.760800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.260400E-02
Grade 1-vs-Grade 3
3.446200E-02
Grade 1-vs-Grade 4
4.512600E-01
Grade 2-vs-Grade 3
7.077200E-01
Grade 2-vs-Grade 4
4.948600E-01
Grade 3-vs-Grade 4
3.760800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.971000E-01
Normal-vs-NonDiabetic
9.133000E-01
Diabetic-vs-NonDiabetic
1.240990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.507600E-01
Normal-vs-NoPancreatitis
8.554200E-01
Pancreatitis-vs-NoPancreatitis
2.529400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.804400E-01
Normal-vs-N1
3.415200E-01
N0-vs-N1
8.608000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.134810E-01
Normal-vs-TP53-NonMutant
6.795600E-01
TP53-Mutant-vs-TP53-NonMutant
1.428150E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
